To investigate whether KIT signaling regulates ZSWIM4 expression in GISTs, GIST cells were treated with imatinib or KIT siRNAs respectively to inhibit KIT activation or expression. This evidence concerns the gene ZSWIM4 and gastrointestinal stromal tumor.